[使用TTF (Optune) 的区域差异]
Sara Kinhult1, Björn Tavelin2, David Löfgren3
1med dr, överläkare, institutionen för kliniska vetenskaper, Lunds universitet; VE onko-logi, Skånes universitetssjukhus.
Lakartidningen
|July 4, 2023
概括
瘤治疗场 (TTF) 显示出质母细胞瘤存活的潜力,但现实世界的吸收和坚持有很大差异. 公平获得这种先进的脑瘤治疗仍然是一个挑战.
科学领域:
- 神经瘤学神经瘤学
- 临床试验分析临床试验分析
- 癌症治疗研究 癌症治疗研究
背景情况:
- 质母细胞瘤是一种具有攻击性的脑瘤,标准治疗是放射治疗和temozolomide.
- 基于随机试验显示生存益处的瘤治疗场 (TTF) 疗法,现在用于表现良好状态的患者.
研究的目的:
- 分析TTF在质母细胞瘤患者中的实际使用模式.
- 在国家队列中评估TTF治疗的接受,坚持和生存结果.
- 为了确定TTF治疗提供的区域差异.
主要方法:
- 从瑞典国家质量注册中心神经系统 (CNS) 瘤数据的分析.
- 评估TTF治疗接受率,中断原因和治疗持续时间.
- 在TTF治疗患者和匹配的对照人群之间比较生存结果.
主要成果:
- 65%的符合条件的质母细胞瘤患者接受了TTF治疗.
- 超过50%的接受治疗的患者因缺乏遵从性或个人选择而停止了TTF治疗,平均治疗持续时间为164天.
- 尽管有国家指导方针,但在提供TTF治疗方面观察到显著的区域差异.
- 与对照组相比,在接受TTF治疗的患者中发现了改善生存率的趋势,尽管在统计学上并不显著.
结论:
- TTF是一种新的质母细胞瘤治疗方法,有可能在现实环境中延长存活时间.
- 目前的TTF治疗并非均地提供给所有符合条件的患者,这表明指南与实践之间存在差距.
- 解决坚持问题和确保公平获取对于优化TTF治疗在质母细胞瘤管理中至关重要.
相关概念视频
01:27Tumor Immunotherapy
573
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
573
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K